DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker

DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker

DDX60, an interferon (IFN)-inducible gene, plays a promotional role in many tumors. However, its function in glioma remains unknown. In this study, bioinformatic analysis (TCGA, CGGA, Rembrandt) illustrated the upregulation and prognostic value of DDX60 in gliomas. Immunohistochemical staining of cl...

Full description

Bibliographic Details
Main Authors: Jingwen Zhang, Minjie Fu, Mengli Zhang, Jinsen Zhang, Zunguo Du, Hongyi Zhang, Wei Hua, Ying Mao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
DDX60
glioma
biomarkers
immune checkpoints
PD-L1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.665360/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.665360/full

Similar Items